Scott Terrillion - 17 Dec 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Sec'y; Chief Compliance & G.C.
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
17 Dec 2021
Net transactions value
$0
Form type
4
Filing time
21 Dec 2021, 16:28:16 UTC
Previous filing
01 Sep 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Award $0 +11,495 +16% $0.000000 82,412 17 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date.